Allergan Names Matthew M. Walsh as Executive VP and CFO
7 February 2018 - - Dublin, Ireland-based specialty pharmaceutical company Allergan plc. (NYSE: AGN) has appointed Matthew M. Walsh as executive vice president and chief financial officer, effective later this month, the company said.
Walsh currently serves as the executive vice president and chief financial officer at Catalent, a role he assumed in 2008. Prior to joining Catalent, he was president, chief financial officer, and acting chief executive officer at Escala Group, Inc.
Walsh is a CFA charterholder who received an MBA from Cornell University, SC Johnson Graduate School of Management, and a BS in Chemical Engineering from Cornell University, College of Engineering.
Allergan is a global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, devices, and biologic products for patients around the world.
The company markets a portfolio of products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories.